Filter
399
Filtered Results: 399
Text search:
Pfizer
Featured
Recommendations
46
New Publications
25
Language
Document type
No document type
100
Studies & Reports
95
Guidelines
82
Fact sheets
43
Manuals
29
Strategic & Response Plan
20
Resource Platforms
10
Situation Updates
5
Training Material
4
Infographics
4
Videos
4
Online Courses
3
Countries / Regions
Brazil
18
Russia
13
Global
11
Argentina
10
South Africa
10
Germany
9
Ukraine
8
Latin America and the Carribbean
7
Middle East and North Africa
7
Mozambique
6
Africa
6
Chile
5
India
5
West and Central Africa
4
Western and Central Europe
4
Ecuador
4
Colombia
3
China
3
Senegal
3
Paraguay
3
East and Southern Africa
3
Nepal
2
Kenya
2
El Salvador
2
Nigeria
2
Peru
2
Philippines
2
South–East Asia Region
2
Eastern Europe
2
Indonesia
2
Liberia
2
Timor Leste/ East Timor
1
Ghana
1
Benin
1
Sierra Leone
1
Kazakhstan
1
Syria
1
Iran
1
Congo-Brazzaville
1
Malawi
1
Guinea-Bissau
1
Tanzania
1
Congo, Democratic Republic of
1
Eastern Europe and Central Asia
1
United Kingdom
1
Belarus
1
Lebanon
1
Bangladesh
1
Uganda
1
Sudan
1
Yemen
1
Angola
1
Chad
1
South Sudan
1
Iraq
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
123
Clinical Guidelines
28
Women & Child Health
18
Public Health
10
Key Resources
5
Capacity Building
3
Pharmacy & Technologies
2
Annual Report MEDBOX
1
Toolboxes
COVID-19
184
Mental Health
37
NTDs
30
TB
17
HIV
15
AMR
12
NCDs
9
Refugee
8
Rapid Response
7
Caregiver
6
Health Financing Toolbox
6
Global Health Education
6
Disability
5
Ebola & Marburg
3
Pharmacy
3
Conflict
3
Planetary Health
2
Specific Hazards
1
Zika
1
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants in current and future COVID-19 vaccine trials. This...
This report’s central premise is that diagnostics and therapeutics, and associated test to treat strategies, are fundamental components of the pandemic response, both for COVID-19 and for future health threats. Two years into the COVID-19 pandemic, this report reflects on the main challenges and k...
Perspectivas sobre las drogas
Responses to epidemics, emergencies and disasters raise many ethical issues for the people involved, including public health specialists and policy makers. This training manual provides material on ethical issues in research, surveillance and patient care in these difficult contexts.
Continuidad de los servicios de salud esenciales: herramienta de evaluación de los centros
recommended
módulo del conjunto de evaluaciones de la capacidad de los servicios de salud en el contexto de la pandemia de COVID-19: orientaciones provisionales, 12 de mayo de 2021; La herramienta de evaluación de la continuidad de los servicios sanitarios esenciales: Herramienta de evaluación de instalacion...
first issued 18 August 2022
This article examines the activities of national and international actors in Pharmaceutical Services (PS) in Mozambique from 2007 to 2012, focusing on the public provision of HIV/Aids, malaria and tuberculosis medicines. It describes how PS functions in the country, what actors are involved in this ...
Diese Faktenboxen sollen Ihnen helfen, Nutzen und Schaden einer Schutzimpfung gegen COVID-19 abzuwägen. Die Informationen und Zahlen stellen keine endgültige Bewertung dar. Sie basieren auf den derzeit besten wissenschaftlichen Erkenntnissen.
Considerations for implementing and adjusting public health and social measures in the context of COVID-19
recommended
interim guidance, 14 June 2021
This document is intended for national authorities and decision makers in countries that have introduced large scale public health and social measures. It offers guidance for adjusting public health and social measures, while managing the risk of a resurgence of cases...
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian...
This policy brief aims to provide a review of the current progress on implementing the Kenya national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing ac...
The Onchocerciasis Control Programme in West Africa (OCP) undertook regional and large scale frght against onchocerciasis in West Africa in 1974 using a vector control strategy. By 2002 OCP had succeeded in eliminating the disease as a public health, socio-economic and development problem in 10 out ...
This policy brief has been developed in response to the contemporary challenge of antibiotic resistance (ABR). ABR poses a formidable threat to global health and sustainable development. It is now increasingly recognized that the systematic neglect of cultural factors is one of the biggest obs...
Rebuilding Liberia’s health system is crucial for improving the country’s overall health outcomes. This annual report highlights key achievements, challenges,and lessons learned in implementing programmes of technical cooperation with the Government of Liberia from January to December 2022. T...
Module appartenant à la série d’évaluations des capacités des services de santé dans le cadre de la pandémie de COVID-19: orientations provisoires, 12 mai 2021. L'outil d'évaluation de la continuité des services de santé essentiels : Facility Assessment Tool peut être utilisé par les pa...
module de la série d’évaluation des capacités des services de santé dans le contexte de la pandémie de COVID-19, 7 juillet 2021
